Related Experiment Videos
Intrinsic obstacles to human immunodeficiency virus type 1 coreceptor switching
Cristina Pastore1, Alejandra Ramos, Donald E Mosier
1Department of Immunology, The Scripps Research Institute, La Jolla, CA 92037, USA.
Journal of Virology
|June 29, 2004
Summary
The human immunodeficiency virus type 1 (HIV-1) coreceptor switch from CCR5 to CXCR4 is delayed by three main obstacles: diminished replication fitness, inefficient coreceptor use, and unique mutation pathways.
Area of Science:
- Virology
- Immunology
- Molecular Biology
Background:
- Human immunodeficiency virus type 1 (HIV-1) infection naturally evolves, often involving a late-stage switch in coreceptor preference from CCR5 to CXCR4.
- This coreceptor switch expands the virus's target cell range and is linked to a worse clinical prognosis.
Purpose of the Study:
- To investigate the obstacles that impede the natural CCR5-to-CXCR4 coreceptor switch in HIV-1 infection.
- To understand the reasons behind the significant delay in the emergence of CXCR4-using HIV-1 variants.
Main Methods:
- Selection of coreceptor switch variants through in vitro target cell replacement.
- Comparative analysis of replication efficiency between parental R5 isolates and switch variants.
- Assessment of sensitivity to CCR5 and CXCR4 inhibitors for parental, transitional, and final variants.
- Detailed mutational analysis of CXCR4-using viruses.
Main Results:
- Most CCR5-to-CXCR4 switch variants exhibited diminished replication fitness compared to their parental R5 isolates.
- Transitional intermediate variants showed increased sensitivity to both CCR5 and CXCR4 inhibitors.
- Mutations enabling CXCR4 use were nonrandom, favoring charged amino acid substitutions, altered N-linked glycosylation sites, and isolate-specific patterns, often arising from G-to-A transitions.
Conclusions:
- Diminished replication fitness, less-efficient coreceptor utilization, and specific mutational pathways collectively explain the prolonged delay in the emergence of CXCR4-using HIV-1.
- Understanding these obstacles provides insights into HIV-1 evolution and pathogenesis.